Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDiSpecimen Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$152.00 | -$152.00 | -$152.00 |
| Q2 2026 | 1 | -$184.00 | -$184.00 | -$184.00 |
| Q1 2027 | 1 | -$200.00 | -$200.00 | -$200.00 |
| Q2 2027 | 1 | -$220.00 | -$220.00 | -$220.00 |
| Q3 2027 | 1 | -$272.00 | -$272.00 | -$272.00 |
| Q4 2027 | 1 | -$300.00 | -$300.00 | -$300.00 |
| Q1 2028 | 1 | -$256.00 | -$256.00 | -$256.00 |
| Q2 2028 | 1 | -$240.00 | -$240.00 | -$240.00 |
| Q3 2028 | 1 | -$280.00 | -$280.00 | -$280.00 |
| Q4 2028 | 1 | -$192.00 | -$192.00 | -$192.00 |
| Q1 2029 | 1 | -$216.00 | -$216.00 | -$216.00 |
| Q2 2029 | 1 | -$224.00 | -$224.00 | -$224.00 |
| Q3 2029 | 1 | -$152.00 | -$152.00 | -$152.00 |
| Q4 2029 | 1 | -$160.00 | -$160.00 | -$160.00 |
| Q1 2030 | 1 | -$176.00 | -$176.00 | -$176.00 |
| Q2 2030 | 1 | -$152.00 | -$152.00 | -$152.00 |
| Q3 2030 | 1 | -$152.00 | -$152.00 | -$152.00 |
| Q4 2030 | 1 | -$152.00 | -$152.00 | -$152.00 |
iSpecimen Inc Earnings Date And Information
iSpecimen Inc last posted its earnings results on Wednesday, April 1st, 2026. The company reported $-23.6 earnings per share for the quarter, topping analysts' consensus estimates of $-152 by $128.4. The company had revenue of 151.94 K for the quarter and had revenue of 1.93 M for the year. iSpecimen Inc has generated $-91 earnings per share over the last year ($-91.15 diluted earnings per share) and currently has a price-to-earnings ratio of -0.02. iSpecimen Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
iSpecimen Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/14/2026 | Q2 2026 | N/A | -$0.98 | N/A | N/A | $151.94 K |
| 05/15/2026 | Q1 2026 | N/A | -$6.66 | N/A | $3.40 M | $156.01 K |
| 04/01/2026 | Q4 2025 | -$152.00 | -$23.59 | 128.41 | $3.40 M | $51.76 K |
| 11/17/2025 | Q3 2025 | -$3.80 | -$19.05 | -15.25 | $3.33 M | $106.59 K |
| 08/14/2025 | Q2 2025 | -$3.80 | -$16.78 | -12.98 | $3.10 M | $713.14 K |
| 05/19/2025 | Q1 2025 | -$4.40 | -$28.55 | -24.15 | $2.55 M | $1.06 M |
| 04/14/2025 | Q4 2024 | -$4.00 | -$251.11 | -247.11 | $2.98 M | $1.48 M |
| 11/07/2024 | Q3 2024 | N/A | -$83.82 | N/A | $2.95 M | $2.66 M |
| 08/06/2024 | Q2 2024 | -$2.24 | -$148.78 | -146.54 | $2.88 M | $2.86 M |
| 05/07/2024 | Q1 2024 | N/A | -$254.22 | N/A | $2.84 M | $2.29 M |
| 03/13/2024 | Q4 2023 | -$4.80 | -$270.57 | -265.77 | $3.04 M | $2.58 M |
| 11/02/2023 | Q3 2023 | N/A | -$186.30 | N/A | $2.24 M | $2.78 M |
| 08/02/2023 | Q2 2023 | -$6.00 | -$308.50 | -302.5 | $3.07 M | $1.63 M |
| 05/04/2023 | Q1 2023 | N/A | -$216.62 | N/A | $2.62 M | $2.95 M |
| 03/30/2023 | Q4 2022 | N/A | -$193.57 | N/A | $2.67 M | $2.96 M |
| 11/08/2022 | Q3 2022 | -$6.80 | -$278.93 | -272.13 | $2.45 M | $2.58 M |
| 08/04/2022 | Q2 2022 | -$0.00 | -$236.40 | -236.4 | $2.87 M | $2.34 M |
| 05/10/2022 | Q1 2022 | -$0.25 | -$217.56 | -217.31 | $2.78 M | $2.52 M |
| 03/22/2022 | Q4 2021 | N/A | -$187.82 | N/A | $3.50 M | $2.55 M |
| 11/04/2021 | Q3 2021 | N/A | -$178.36 | N/A | N/A | $2.72 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
iSpecimen Inc Earnings: FAQ's
In the previous quarter, iSpecimen Inc (:ISPC) reported $-23.6 earnings per share (EPS) to beat the analysts' consensus estimate of $-152 by $128.4.
The conference call for iSpecimen Inc's latest earnings report can be listened to online.
The conference call transcript for iSpecimen Inc's latest earnings report can be read online.
iSpecimen Inc (:ISPC) has a recorded annual revenue of $1.93 M.
iSpecimen Inc (:ISPC) has a recorded net income of $-10,487,532.iSpecimen Inc has generated $-91.15 earnings per share over the last four quarters.
iSpecimen Inc (:ISPC) has a price-to-earnings ratio of -0.02 and price/earnings-to-growth ratio is -0.